128 related articles for article (PubMed ID: 34942295)
41. Pyoderma gangrenosum in an infant: A case report and review of the literature.
Crouse L; McShane D; Morrell DS; Wu EY
Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
[TBL] [Abstract][Full Text] [Related]
42. Pyoderma gangrenosum in an infant.
Torrelo A; Colmenero I; Serrano C; Vilanova A; Naranjo R; Zambrano A
Pediatr Dermatol; 2006; 23(4):338-41. PubMed ID: 16918628
[TBL] [Abstract][Full Text] [Related]
43. Imatinib induced pyoderma gangrenosum.
Pinato DJ; Sharma R
J Postgrad Med; 2013; 59(3):244-5. PubMed ID: 24029213
[No Abstract] [Full Text] [Related]
44. Pyoderma Gangrenosum Under Dabrafenib and Trametinib for Metastatic Melanoma.
Saint-Jean M; Le Moigne M; Daguze J; Bossard C; Peuvrel L; Quéreux G; Dréno B
Acta Derm Venereol; 2018 Apr; 98(5):530-531. PubMed ID: 29362816
[No Abstract] [Full Text] [Related]
45. Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma.
Meunier M; Larabi A; Schacherer M; Deteix C; Courby S; Cahn JY
Ann Hematol; 2020 Feb; 99(2):379-380. PubMed ID: 31822948
[No Abstract] [Full Text] [Related]
46. Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness.
Ariane M; Bouaziz JD; de Masson A; Jachiet M; Bagot M; Lepelletier C
Dermatol Ther; 2019 Jan; 32(1):e12774. PubMed ID: 30341800
[TBL] [Abstract][Full Text] [Related]
47. Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.
Sawka E; Zhou A; Latour E; Friedman M; Ortega-Loayza AG
Clin Rheumatol; 2021 Oct; 40(10):3963-3969. PubMed ID: 34002351
[TBL] [Abstract][Full Text] [Related]
48. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
Argüelles-Arias F; Castro-Laria L; Lobatón T; Aguas-Peris M; Rojas-Feria M; Barreiro-de Acosta M; Soto-Escribano P; Calvo-Moya M; Ginard-Vicens D; Chaparro-Sánchez M; Hernández-Durán M; Castro-Senosiain B; Fernández-Villaverde A; García-Sánchez V; Domínguez-Muñoz E; Caunedo-Álvarez A; Herrerías-Gutiérrez JM
Dig Dis Sci; 2013 Oct; 58(10):2949-54. PubMed ID: 23828140
[TBL] [Abstract][Full Text] [Related]
49. [Pyoderma gangrenosum: a complication following surgery for carpal tunnel syndrome].
Geerards D; de Wit T; Dolmans GHCG
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31166097
[TBL] [Abstract][Full Text] [Related]
50. Pyoderma gangrenosum associated with chronic recurrent multifocal osteomyelitis as a possible paradoxical reaction to anti-tumor necrosis factor-α therapy.
Katsuo K; Honda T; Kaku Y; Nishitani-Isa M; Honda Y; Yasumi T; Kabashima K
J Dermatol; 2020 Aug; 47(8):e283-e284. PubMed ID: 32515066
[No Abstract] [Full Text] [Related]
51. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine.
Futami H; Kodaira M; Furuta T; Hanai H; Kaneko E
J Gastroenterol; 1998 Jun; 33(3):408-11. PubMed ID: 9658322
[TBL] [Abstract][Full Text] [Related]
52. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream.
Patel GK; Rhodes JR; Evans B; Holt PJ
J Dermatolog Treat; 2004 Apr; 15(2):122-5. PubMed ID: 15204166
[TBL] [Abstract][Full Text] [Related]
53. Response to the Letter to the Editor: "Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine".
Dos Santos CHM; Koga GA
Inflamm Bowel Dis; 2021 Oct; 27(10):e118. PubMed ID: 34003266
[No Abstract] [Full Text] [Related]
54. Use of infliximab in pyoderma gangrenosum.
Hewitt D; Tait C
Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
[TBL] [Abstract][Full Text] [Related]
55. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.
López San Román A; Bermejo F; Aldanondo I; Carrera E; Boixeda D; Muñoz Zato E
Rev Esp Enferm Dig; 2004 Jun; 96(6):420-2; 422-4. PubMed ID: 15230672
[TBL] [Abstract][Full Text] [Related]
56. Pathophysiology of pyoderma gangrenosum (PG): an updated review.
Braswell SF; Kostopoulos TC; Ortega-Loayza AG
J Am Acad Dermatol; 2015 Oct; 73(4):691-8. PubMed ID: 26253362
[TBL] [Abstract][Full Text] [Related]
57. [Pyoderma gangrenosum treated successfully with visilizumab in patients with ulcerative colitis].
Lorincz M; Kleszky M; Szalóki T; Szalóki T
Orv Hetil; 2010 Jan; 151(4):144-7. PubMed ID: 20071320
[TBL] [Abstract][Full Text] [Related]
58. Annular crystalline keratopathy in association with immunoglobulin therapy for pyoderma gangrenosum.
Budde M; Gusek-Schneider GC; Mayer U; Seitz B
Cornea; 2003 Jan; 22(1):82-5. PubMed ID: 12502958
[TBL] [Abstract][Full Text] [Related]
59. Pyoderma gangrenosum (PG) associated with levamisole-adulterated cocaine: Clinical, serologic, and histopathologic findings in a cohort of patients.
Jeong HS; Layher H; Cao L; Vandergriff T; Dominguez AR
J Am Acad Dermatol; 2016 May; 74(5):892-8. PubMed ID: 26785804
[TBL] [Abstract][Full Text] [Related]
60. Combination immunosuppressant therapy for rapidly progressive pyoderma gangrenosum in a child.
Kawabe S; Iwata N; Nishida E; Kohagura T; Abe N; Nakaseko H; Morita A
Mod Rheumatol Case Rep; 2021 Jan; 5(1):137-140. PubMed ID: 33016252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
